What happens when an exceptional cancer survivor is identified?

The science

Rosalind Study

Publication Date:

What happens when a gene or target is identified in an exceptional cancer survivor?

In this video, we follow the journey of “Gene51”: a discovery that begins with one individual and moves through our entire platform. Step by step, this journey reflects how we work: from identifying unique biological signals to analyzing them across our technologies to better understand what makes long-term survival possible. Through this story, we share a clear and human view of our process. It is a journey driven by science, shaped by data and grounded in a simple idea: every survivor has something to teach us.

Watch Gene51's journey!


Updated: May 18, 2026

UNTIL ALL SURVIVE.

From frontline caregivers and patients to researchers and media voices, we bring diverse perspectives together to advance cancer research. Let’s talk.

UNTIL ALL SURVIVE.

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.

©2024 Cure51, All Rights Reserved

©2026 Cure51, All Rights Reserved

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.